Anna C K M Bebe, Kirstine Moll Harboe, Camilla Nøjgaard
Stenmaglevej 1, Brønshøj.
Ugeskrift for laeger 2012 Oct 1Infliximab is indicated for treatment of plaque psoriasis when traditional systemic therapy is inadequate or inappropriate. The treatment is efficient but also carries a risk of serious adverse drug events. We describe a case of neurological symptoms following the first infusion of infliximab in a patient treated for plaque psoriasis. The patient fully recovered after sensation of the therapy. We believe the symptoms could be related to infliximab and stress the importance of thorough information of patients treated with tumour necrosis factor-α-inhibitors, also about the risk of serious adverse events.
Anna C K M Bebe, Kirstine Moll Harboe, Camilla Nøjgaard. Neurological symptoms following infusion of infliximab]. Ugeskrift for laeger. 2012 Oct 1;174(40):2388-90
PMID: 23031302
View Full Text